Evidence map›Paper›PMID 36737694›Full record

ArticleBMC bioinformatics2023

SSELM-neg: spherical search-based extreme learning machine for drug-target interaction prediction.

Lingzhi Hu, Chengzhou Fu, Zhonglu Ren, Yongming Cai, Jin Yang, Siwen Xu, Wenhua Xu, Deyu Tang

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lingzhi HuSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Chengzhou FuSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Zhonglu RenSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Yongming CaiSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Jin YangSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Siwen XuSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Wenhua XuSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Deyu TangSchool of Medical Information Engineering, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China. scutdy@126.com.
Guangdong Pharmaceutical University · CN

Funding

National Natural Science Foundation of China 61976239Natural Science Foundation of Guangdong Province 2020A1515010783
6 · The paper itself

Abstract

backgroundThe experimental verification of a drug discovery process is expensive and time-consuming. Therefore, efficiently and effectively identifying drug-target interactions (DTIs) has been the focus of research. At present, many machine learning algorithms are used for predicting DTIs. The key idea is to train the classifier using an existing DTI to predict a new or unknown DTI. However, there are various challenges, such as class imbalance and the parameter optimization of many classifiers, that need to be solved before an optimal DTI model is developed.

methodsIn this study, we propose a framework called SSELM-neg for DTI prediction, in which we use a screening approach to choose high-quality negative samples and a spherical search approach to optimize the parameters of the extreme learning machine.

resultsThe results demonstrated that the proposed technique outperformed other state-of-the-art methods in 10-fold cross-validation experiments in terms of the area under the receiver operating characteristic curve (0.986, 0.993, 0.988, and 0.969) and AUPR (0.982, 0.991, 0.982, and 0.946) for the enzyme dataset, G-protein coupled receptor dataset, ion channel dataset, and nuclear receptor dataset, respectively.

conclusionThe screening approach produced high-quality negative samples with the same number of positive samples, which solved the class imbalance problem. We optimized an extreme learning machine using a spherical search approach to identify DTIs. Therefore, our models performed better than other state-of-the-art methods.

Indexed as

Drug DevelopmentDrug DiscoveryAlgorithmsDrug InteractionsMachine LearningClass imbalanceDrug discoveryDrug–target interactionsExtreme learning machineSpherical search

Identifiers

PMID36737694
PMCPMC9896467
OpenAlexW4319159275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.